Compass Oncology - East — Tualatin, Oregon

Compass Oncology - East is a clinical research site located in Tualatin, Oregon, United States 97062.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Compass Oncology - East has participated in 1 clinical trials.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC).

Sponsors: Constellation Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tualatin

Browse all research sites in Oregon · View every site in Tualatin

• Legacy Meridian Park Hospital
• Oregon Health and Science University - CHO Tualatin
• Northwest Cancer Specialists PC
• Northwest Cancer Specialists, P.C.
• Research Site
• Connall Consmetic Surgery
• Spinal Diagnostics
• Legacy Meridian Park Medical Center
• Northwest Cancer Specialists
• Pfizer Investigational Site
• OHSU Knight Cancer Institute, Tualatin
• Oregon Spine Care

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology - East?

Compass Oncology - East has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology - East conducted?

Compass Oncology - East has 1 clinical trials on record. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC).

Is Compass Oncology - East accredited by Crixeo Clinical Trials?

Compass Oncology - East has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Oncology - East?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.